KOC
ABBV icon

Koss-Olinger Consulting’s AbbVie ABBV Stock Holding History

Koss-Olinger Consulting’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$254K Sell
1,168
-1,081
-48% -$240K 0.02% 235
2025
Q4 		$514K Sell
2,249
-664
-23% -$151K 0.04% 166
2025
Q3 		$541K Hold
2,913
– – 0.04% 189
2025
Q2 		$541K Sell
2,913
-67
-2% -$12.5K 0.04% 191
2025
Q1 		$624K Buy
+2,980
New +$579K 0.05% 158
2024
Q4 		– Sell
-2,566
Closed -$507K – 186
2024
Q3 		$507K Buy
2,566
+400
+18% +$74.7K 0.04% 159
2024
Q2 		$371K Buy
+2,166
New +$359K 0.03% 183
2024
Q1 		– Sell
-1,912
Closed -$296K – 47
2023
Q4 		$296K Sell
1,912
-46
-2% -$6.71K 0.03% 239
2023
Q3 		$292K Buy
1,958
+280
+17% +$41.1K 0.04% 194
2023
Q2 		$226K Hold
1,678
– – 0.03% 234
2023
Q1 		$267K Sell
1,678
-161
-9% -$24.6K 0.03% 188
2022
Q4 		$297K Sell
1,839
-654
-26% -$100K 0.04% 161
2022
Q3 		$335K Buy
2,493
+318
+15% +$45.6K 0.06% 133
2022
Q2 		$333K Sell
2,175
-616
-22% -$94.1K 0.06% 120
2022
Q1 		$452K Sell
2,791
-1,227
-31% -$178K 0.07% 108
2021
Q4 		$544K Buy
4,018
+336
+9% +$39.7K 0.08% 98
2021
Q3 		$397K Sell
3,682
-1,121
-23% -$128K 0.06% 141
2021
Q2 		$541K Buy
4,803
+421
+10% +$47.4K 0.08% 126
2021
Q1 		$474K Buy
+4,382
New +$469K 0.08% 132

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Koss-Olinger Consulting's ABBV Position: Q1 2026 in Review

Koss-Olinger Consulting reduced its AbbVie (ABBV) stake by 48% in Q1 2026, selling an estimated $240K and leaving 1,168 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #235.

Koss-Olinger Consulting first reported a position in ABBV in Q1 2021 and has held it in 19 quarters since. The position peaked at $624K in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Koss-Olinger Consulting held 1,168 shares of AbbVie worth $254K as of Q1 2026.
  • Koss-Olinger Consulting sold 1,081 AbbVie shares in Q1 2026, an estimated $240K.
  • AbbVie made up 0.02% of Koss-Olinger Consulting's portfolio in Q1 2026, its #235 holding.
  • Koss-Olinger Consulting first reported a position in AbbVie in Q1 2021 and has held it in 19 quarters since.
  • Koss-Olinger Consulting's AbbVie position peaked at $624K in Q1 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.